Klotman meets BCM family at town hall meetings
Baylor College of Medicine faculty and staff had the chance to meet Dr. Paul Klotman, the new president and CEO, in a series of town hall meetings held last month.
Klotman, a recognized leader in academic medicine, was named the fifth president in BCM's history June 21. He was unanimously selected by the Baylor College of Medicine Board of Trustees. Klotman, currently the chair of medicine at Mount Sinai School of Medicine in New York City, will start Sept. 1. See announcement package.
He is eager to join Baylor, and noted that he is especially enthusiastic about the family feel at BCM, something that not every institution can offer.
"Baylor is a fantastic institution – a top academic institution worldwide," said Klotman. "Its academic strengths are well known, it has an outstanding clinical reputation and a terrific scientific base. I am eager to contribute my part to its future."
Klotman, who hails from the Midwest and is from a family of academics, touched on several common themes during his three town hall meetings on the Baylor campus:
- Continued growth for the medical school, including moving up in the national rankings.
- Faculty group practice growth.
- The college's ability to meet the challenges it faces.
Klotman also touched on the issue of the lack of primary care physicians; a health care model called accountable care; the long-term goal of increasing NIH funding; and increasing the international experience for trainees.
Activities at Mt. Sinai
He joined the Mt. Sinai faculty in 1994 as chief of the division of nephrology. He was selected chair in 2001. A noted scientist, his work has included both basic and clinical research in molecular virology and AIDS pathogenesis. He plans to move his laboratory here later this year.
During the time he was chair of medicine at Mt. Sinai, the department's NIH rank went from 24th to 14th, and funding from $37.8 million to $74.8 million. Klotman recruited six new division chiefs, implemented a new faculty compensation plan and zero-based budgeting and grew clinical revenue by 15 percent each year, while continuing to be a funded NIH investigator and the principal investigator of a program project grant in nephrology.
He redesigned the residency curriculum at Mt. Sinai with a focus on academic medicine. In his career he has trained over 50 clinical fellows, postdoctoral fellows and students. Four of those he mentored are now chairs of medicine and four others lead major institutions or centers.
Klotman received his bachelor's degree from the University of Michigan in 1972 and his medical degree from Indiana University in 1976. He completed his medicine and nephrology residency training at Duke University Medical Center. After training he joined the Duke faculty and reached the rank of associate professor of medicine before moving to the NIH in 1988. He became chief of the Molecular Medicine Section in the Laboratory of Developmental Biology at NIH and, in 1993, became chief of the Viral Pathogenesis Laboratory.
He is married to Dr. Mary E. Klotman, chair of medicine at Duke University School of Medicine, and they have two sons who are college students.
He will succeed Dr. William T. Butler, who has been serving as interim president and CEO since December 2008. Butler, president of the college from 1979 to 1996, also serves as chancellor emeritus.
The search committee, which began its work early this year, included faculty members and board trustees. The advisory committee to the search committee included deans, and representatives of alumni, medical school students, graduate school students and residents.
"We enthusiastically welcome Dr. Klotman to take the helm of Baylor College of Medicine. He had unanimous support from the search committee," said Marc J. Shapiro, chair of the BCM Board of Trustees. "He is a proven leader in all of the areas that are important to us – medical education, scientific research and patient care. He is the ideal choice."
You can send a welcome note to Dr. Paul Klotman at email@example.com.